Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Jingfeng Medical's public offering portion in its Hong Kong IPO was oversubscribed by 1,091.94 times
According to an announcement by the Hong Kong Stock Exchange, Shenzhen Jingfeng Medical raised HK$1.2 billion (approximately US$154 million) in its initial public offering (IPO) in Hong Kong. The offering price was HK$43.24 per share. The public offering portion initially offered 2.77 million shares, with an oversubscription ratio of 1,091.94 times. The international offering portion initially offered 24.95 million shares, with an oversubscription ratio of 25.18 times.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report




